ERBB2 and non-small cell lung carcinoma: This finding is also mirrored in another retrospective study, which found only eight patients (out of 12946 NSCLC patients) who had both EGFR and HER2 mutations; of these eight patients, six patients had sensitising EGFR mutations and exon eight HER2 mutation (S310F/Y) [37].